Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay

Claudio U. Köser; Iñaki Comas; Silke Feuerriegel; Stefan Niemann; Sebastien Gagneux; Sharon J. Peacock

doi:10.1016/j.tube.2014.04.002

Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay

Claudio U. Köser^*, Iñaki Comas, Silke Feuerriegel, Stefan Niemann, Sebastien Gagneux, Sharon J. Peacock

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

11 Citations (Scopus)

Original language	English
Pages (from-to)	451-453
Number of pages	3
Journal	Tuberculosis
Volume	94
Issue number	4
DOIs	https://doi.org/10.1016/j.tube.2014.04.002
Publication status	Published - Jul 2014

Bibliographical note

Funding Information:
This publication presents independent research supported by the Health Innovation Challenge Fund (HICF-T5-342 and WT098600), a parallel funding partnership between the Department of Health and Wellcome Trust. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health or Wellcome Trust.

Funding Information:
This work was supported by a grant from the Department of Health , Wellcome Trust and the Health Innovation Challenge Fund ( HICF-T5-342 and WT098600 ) and Public Health England (to S.J.P.). C.U.K. is a Junior Research Fellow at Wolfson College, Cambridge. I.C. is supported by the Spanish Government (Ramón y Cajal programme RYC-2012-10627).

Keywords

Mycobacterium tuberculosis complex
Phylogenetic diversity
Pyrazinamide resistance

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.tube.2014.04.002

Cite this

@article{40576770455b4721bb5f3f1aaafdedae,

title = "Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay",

keywords = "Mycobacterium tuberculosis complex, Phylogenetic diversity, Pyrazinamide resistance",

author = "K{\"o}ser, {Claudio U.} and I{\~n}aki Comas and Silke Feuerriegel and Stefan Niemann and Sebastien Gagneux and Peacock, {Sharon J.}",

note = "Funding Information: This publication presents independent research supported by the Health Innovation Challenge Fund (HICF-T5-342 and WT098600), a parallel funding partnership between the Department of Health and Wellcome Trust. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health or Wellcome Trust. Funding Information: This work was supported by a grant from the Department of Health , Wellcome Trust and the Health Innovation Challenge Fund ( HICF-T5-342 and WT098600 ) and Public Health England (to S.J.P.). C.U.K. is a Junior Research Fellow at Wolfson College, Cambridge. I.C. is supported by the Spanish Government (Ram{\'o}n y Cajal programme RYC-2012-10627). ",

year = "2014",

month = jul,

doi = "10.1016/j.tube.2014.04.002",

language = "English",

volume = "94",

pages = "451--453",

journal = "Tuberculosis",

issn = "1472-9792",

publisher = "Elsevier",

number = "4",

}

Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay. / Köser, Claudio U.; Comas, Iñaki; Feuerriegel, Silke; Niemann, Stefan; Gagneux, Sebastien; Peacock, Sharon J.

In: Tuberculosis, Vol. 94, No. 4, 07.2014, p. 451-453.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay

AU - Köser, Claudio U.

AU - Comas, Iñaki

AU - Feuerriegel, Silke

AU - Niemann, Stefan

AU - Gagneux, Sebastien

AU - Peacock, Sharon J.

N1 - Funding Information: This publication presents independent research supported by the Health Innovation Challenge Fund (HICF-T5-342 and WT098600), a parallel funding partnership between the Department of Health and Wellcome Trust. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health or Wellcome Trust. Funding Information: This work was supported by a grant from the Department of Health , Wellcome Trust and the Health Innovation Challenge Fund ( HICF-T5-342 and WT098600 ) and Public Health England (to S.J.P.). C.U.K. is a Junior Research Fellow at Wolfson College, Cambridge. I.C. is supported by the Spanish Government (Ramón y Cajal programme RYC-2012-10627).

PY - 2014/7

Y1 - 2014/7

KW - Mycobacterium tuberculosis complex

KW - Phylogenetic diversity

KW - Pyrazinamide resistance

UR - http://www.scopus.com/inward/record.url?scp=84902543317&partnerID=8YFLogxK

U2 - 10.1016/j.tube.2014.04.002

DO - 10.1016/j.tube.2014.04.002

M3 - Letter

C2 - 24870943

AN - SCOPUS:84902543317

VL - 94

SP - 451

EP - 453

JO - Tuberculosis

JF - Tuberculosis

SN - 1472-9792

IS - 4

ER -

Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Cite this